Jérôme Busserolles

ResearcherID Loop profile Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 7

Top Topics

Neuropathic Pain

Botulinum Toxin

Top Venues

Expert opinion on drug safety

The Journal of neuroscience : the official journal of the Society for Neuroscience

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Sylvain Lamoine, Mélissa Cumenal, David André Barrière, Vanessa Pereira, Mathilde Fereyrolles, Laëtitia Prival, Julie Barbier, Ludivine Boudieu, Emilie Brasset, Benjamin Bertin, Yoan Renaud, Elisabeth Miot-Noirault, Marie-Ange Civiale, David Balayssac, Youssef Aissouni, Alain Eschalier, Jérôme Busserolles
The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice. International journal of molecular sciences 23 (1) (2021)
Marie Selvy, Bruno Pereira, Nicolas Kerckhove, Jérôme Busserolles, Fadila Farsi, Virginie Guastella, Patrick Merle, Denis Pezet, David Balayssac
Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists' professional practices. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 29 (7) (2021)
Vanessa Pereira, Sylvain Lamoine, Mélissa Cuménal, Stéphane Lolignier, Youssef Aissouni, Anne Pizzoccaro, Laetitia Prival, David Balayssac, Alain Eschalier, Emmanuel Bourinet, Jérôme Busserolles
Epigenetics Involvement in Oxaliplatin-Induced Potassium Channel Transcriptional Downregulation and Hypersensitivity. Molecular neurobiology 58 (7) (2021)
Mélissa Cuménal, Marie Selvy, Nicolas Kerckhove, Célian Bertin, Margaux Morez, Christine Courteix, Jérôme Busserolles, David Balayssac
The Safety of Medications used to Treat Peripheral Neuropathic Pain, Part 2 (Opioids, Cannabinoids and Other Drugs): review of Double-Blind, Placebo-Controlled, Randomized Clinical Trials. Expert opinion on drug safety 20 (1) (2020)
Marie Selvy, Mélissa Cuménal, Nicolas Kerckhove, Christine Courteix, Jérôme Busserolles, David Balayssac
The safety of medications used to treat peripheral neuropathic pain, part 1 (antidepressants and antiepileptics): review of double-blind, placebo-controlled, randomized clinical trials. Expert opinion on drug safety 19 (6) (2020)
Jérôme Busserolles, Ismail Ben Soussia, Laetitia Pouchol, Nicolas Marie, Mathieu Meleine, Maïly Devilliers, Céline Judon, Julien Schopp, Loïc Clémenceau, Laura Poupon, Eric Chapuy, Serge Richard, Florence Noble, Florian Lesage, Sylvie Ducki, Alain Eschalier, Stéphane Lolignier
TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects. British journal of pharmacology 177 (20) (2020)
Stéphane Lolignier, Dimitra Gkika, David A Andersson, Enrico Leipold, Irina Vetter, Felix Viana, Jacques Noël, Jérôme Busserolles
New Insight in Cold Pain: Role of Ion Channels, Modulation, and Clinical Perspectives. The Journal of neuroscience : the official journal of the Society for Neuroscience 36 (45) (2017)